# EDGAR Filing Document

**Accession Number:** 0001009919
**File Stem:** 0001683168-25-007032
**Filing Date:** 2025-9
**Character Count:** 5420
**Document Hash:** 0f165ddb9245f55d40c31475ee184d46
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-25-007032.hdr.sgml**: 20250916

**ACCESSION NUMBER**: 0001683168-25-007032

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250908

**ITEM INFORMATION**: Other Events

**FILED AS OF DATE**: 20250916

**DATE AS OF CHANGE**: 20250916

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Invech Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001009919
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 880419476
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-25553
- **FILM NUMBER:** 251317269

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 26496
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85255
- **BUSINESS PHONE:** 602-793-8058

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 26496
- **CITY:** SCOTTSDALE
- **STATE:** AZ
- **ZIP:** 85255

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Amersin Life Sciences CORP
- **DATE OF NAME CHANGE:** 20050301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HUBEI PHARMACEUTICAL GROUP LTD
- **DATE OF NAME CHANGE:** 20030409

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PAN ASIA COMMUNICATIONS CORP
- **DATE OF NAME CHANGE:** 19990224

?xml version='1.0' encoding='ASCII'? Invech Holdings, Inc. Form 8-K

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of report (Date of earliest event reported): **September 8, 2025**

**INVECH HOLDINGS, INC.**

(Exact Name of Registrant as Specified in Its Charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-25553** | **98-0419476** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

**7339 E. Williams Drive**

**Unit 26496**

**Scottsdale, AZ 85255**

(Address of Principal Executive Offices) (Zip Code)

Registrant's Telephone Number, Including Area Code: **(602) 793-8058**

**Not Applicable**

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Securities registered pursuant to Section 12(b) of the Act: None

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.001 per share | IVHI | OTC Markets |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Section 8 - Other Events**

**Item 8.01 Other Events**

On September 8, 2025, the company was notified that the Financial Industry Regulatory Authority (FINRA) deemed the Form 15c2-11 (the "Form 211") effective. The Form 211 filing was submitted by Glendale Securities, Inc. for the company's common stock. The effectiveness allows Glendale Securities, Inc. to resume publishing quotes for the company's common stock in an over-the-counter (OTC) quotation medium. The effectiveness of the Form 211 is a significant step that increases the visibility and liquidity of the company's common stock in the public market. The company continues to work with its partners to further its presence in the market and provide more transparent and timely information to its shareholders and the broader investment community.

**Safe Harbor Statement**

This Form 8-K contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties. The company's actual results could differ materially from those contemplated by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the timing and success of market-making activities and general market conditions. The company undertakes no obligation to update any forward-looking statement for any reason, except as required by law.

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

**Invech Holdings, Inc.**

DATE: September 16, 2025

By: <u>/s/Rhonda Keaveney</u>

Name: Rhonda Keaveney

Title: CEO